Literature DB >> 22829497

Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair.

Hui Xue1, Xiu-Ying Zhang, Jia-Mei Liu, Yu Song, Yi-Fan Li, Dong Chen.   

Abstract

Bridging strategies are essential for spinal cord repair in order to provide a physical substrate allowing axons to grow across the site of spinal cord lesions. In this study, we have evaluated the therapeutic effects of adding amniotic epithelial cells to a unidirectionally oriented acellular muscle scaffold and have compared this with the effect of a scaffold alone. Chemically extracted acellular muscles, with or without amniotic epithelial cells, were implanted into the lateral hemisected adult rat thoracic spinal cord. Control rats were similarly injured. After 4 weeks, the acellular muscle scaffolds were found to be well integrated with the host tissue. The chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells promoted axonal growth in a distinctly organized and linear fashion, induced sprouting of calcitonin gene-related peptide positive axons, and was not associated with an astrocyte response. Compared with acellular muscle scaffolds alone, the addition of amniotic epithelial cells further promoted the remyelination of nerve fibers, sprouting of 5-hydroxytryptamine nerve fibers, relays of cortical motor-evoked potential and cortical somatosensory-evoked potential, and functional recovery. All these data together suggest that co-implantation of chemically extracted acellular muscle with amniotic epithelial cells may constitute a valuable approach to study and/or develop therapies for spinal cord injury.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829497     DOI: 10.1002/jbm.a.34311

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

Review 1.  Biomaterials for spinal cord repair.

Authors:  Agnes E Haggerty; Martin Oudega
Journal:  Neurosci Bull       Date:  2013-07-18       Impact factor: 5.203

Review 2.  Developing Extracellular Matrix Technology to Treat Retinal or Optic Nerve Injury(1,2,3).

Authors:  Tanchen Ren; Yolandi van der Merwe; Michael B Steketee
Journal:  eNeuro       Date:  2015-10-08

3.  The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration.

Authors:  Rosaliana Libro; Placido Bramanti; Emanuela Mazzon
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

Review 4.  The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.

Authors:  Eun Young Kim; Kyung-Bon Lee; Min Kyu Kim
Journal:  BMB Rep       Date:  2014-03       Impact factor: 4.778

5.  Labeling Adipose-Derived Stem Cells with Hoechst 33342: Usability and Effects on Differentiation Potential and DNA Damage.

Authors:  P Schendzielorz; K Froelich; K Rak; T Gehrke; A Scherzad; R Hagen; A Radeloff
Journal:  Stem Cells Int       Date:  2016-06-08       Impact factor: 5.443

Review 6.  The Science and Clinical Applications of Placental Tissues in Spine Surgery.

Authors:  K Aaron Shaw; Stephen A Parada; David M Gloystein; John G Devine
Journal:  Global Spine J       Date:  2018-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.